No price change in 78% of actively used drugs: NPPA

 Drug pricing regulator NPPA on Friday said prices of around 78% of “actively used” drugs will remain unaffected after the rollout of GST.

The National Pharmaceutical Pricing Authority (NPPA) has already announced provisional ceiling prices of 761 medicines, including anti-cancer, HIV, diabetes and antibiotics, with a majority being reduced ahead of the implementation of GST.

The prices will be notified as formally revised ceiling prices immediately after GST notification, NPPA had said in a memorandum earlier this week.

“Prices of approximately 78% of all actively used and traded drugs in the country are going to remain unaffected post GST," NPPA tweeted on Friday.

It had earlier indicated that the prices of a majority of essential drugs would increase by up to 2.29% when the GST regime kicks in.